Ávila-Moreno F, Armas-López L, Álvarez-Moran AM, López-Bujanda Z, Ortiz-Quintero B, Hidalgo-Miranda A, Urrea-Ramírez F, Rivera-Rosales RM, Vázquez-Manríquez E, Peña-Mirabal E, Morales-Gómez J, Vázquez-Minero JC, Téllez-Becerra JL, Ramírez-Mendoza R, Ávalos-Bracho A, de Alba EG, Vázquez-Santillán K, Maldonado-Lagunas V, Santillán-Doherty P, Piña-Sánchez P, Zúñiga-Ramos J (2014) Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosis. PLoS ONE 9(12):e114104

Article  PubMed  PubMed Central  Google Scholar 

Bade BC, Dela Cruz CS (2020) Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med 41(1):1–24

Article  PubMed  Google Scholar 

Baykara O, Bakir B, Buyru N, Kaynak K, Dalay N (2015) Amplification of chromosome 8 genes in lung cancer. J Cancer 6(3):270–275

Article  PubMed  PubMed Central  Google Scholar 

Bi HX, Shi HB, Zhang T, Cui G (2015) PRDM14 promotes the migration of human non-small cell lung cancer through extracellular matrix degradation in vitro. Chin Med J 128(3):373–377

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casamassimi A, Rienzo M, Di Zazzo E, Sorrentino A, Fiore D, Proto MC, Moncharmont B, Gazzerro P, Bifulco M, Abbondanza C (2020) Multifaceted role of PRDM proteins in human cancer. Int J Mol Sci 21(7):2648

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan YS, Göke J, Lu X, Venkatesan N, Feng B, Su IH, Ng HH (2013) A PRC2-dependent repressive role of PRDM14 in human embryonic stem cells and induced pluripotent stem cell reprogramming. Stem Cells (Dayton, Ohio) 31(4):682–692

Article  CAS  PubMed  Google Scholar 

Ferrer I, Zugazagoitia J, Herbertz S, John W, Paz-Ares L, Schmid-Bindert G (2018) KRAS-mutantnon-small cell lung cancer: from biology to therapy. Lung Cancer (Amsterdam, Netherlands) 124:53–64

Article  PubMed  Google Scholar 

Gollob JA, Wilhelm S, Carter C, Kelley SL (2006) Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol 33(4):392–406

Article  CAS  PubMed  Google Scholar 

Heigener DF, Gandara DR, Reck M (2015) Targeting of MEK in lung cancer therapeutics. Lancet Respir Med 3(4):319–327

Article  CAS  PubMed  Google Scholar 

Herbst RS, Morgensztern D, Boshoff C (2018) The biology and management of non-small cell lung cancer. Nature 553(7689):446–454

Article  CAS  PubMed  Google Scholar 

Huang X, Fu C, Liu W, Liang Y, Li P, Liu Z, Sheng Q, Liu P (2019) Chemerin-induced angiogenesis and adipogenesis in 3 T3–L1 preadipocytes is mediated by lncRNA Meg3 through regulating Dickkopf-3 by sponging miR-217. Toxicol Appl Pharmacol 385:114815

Article  CAS  PubMed  Google Scholar 

Kurdistani SK (2011) Histone modifications in cancer biology and prognosis. Progress Drug Res 67:91–106

CAS  Google Scholar 

Laugesen A, Højfeldt JW, Helin K (2019) Molecular mechanisms directing PRC2 recruitment and H3K27 methylation. Mol Cell 74(1):8–18

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ma J, Wang N, Zhang Y, Wang C, Ge T, Jin H, Deng X, Huo X, Gu D, Ge Z, Chu W, Jiang L, Qin W (2015) KDM6B elicits cell apoptosis by promoting nuclear translocation of FOXO1 in non-small cell lung cancer. Cell Physiol Biochem 37(1):201–213

Article  CAS  PubMed  Google Scholar 

Mallol A, Guirola M, Payer B (2019) PRDM14 controls X-chromosomal and global epigenetic reprogramming of H3K27me3 in migrating mouse primordial germ cells. Epigenet Chromatin 12(1):38

Article  Google Scholar 

Marampon F, Ciccarelli C, Zani BM (2006) Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Mol Cancer 5:31

Article  PubMed  PubMed Central  Google Scholar 

Mehta A, Dobersch S, Romero-Olmedo AJ, Barreto G (2015) Epigenetics in lung cancer diagnosis and therapy. Cancer Metastasis Rev 34(2):229–241

Article  CAS  PubMed  Google Scholar 

Mzoughi S, Zhang J, Hequet D, Teo SX, Fang H, Xing QR, Bezzi M, Seah MKY, Ong SLM, Shin EM, Wollmann H, Wong ESM, Al-Haddawi M, Stewart CL, Tergaonkar V, Loh YH, Dunn NR, Messerschmidt DM, Guccione E (2017) PRDM15 safeguards naive pluripotency by transcriptionally regulating WNT and MAPK-ERK signaling. Nat Genet 49(9):1354–1363

Article  CAS  PubMed  Google Scholar 

Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Lee PW, Ikeda Y (2007) The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells. Mol Ther 15(8):1531–1536

Article  CAS  PubMed  Google Scholar 

Oser MG, Niederst MJ, Sequist LV, Engelman JA (2015) Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin. Lancet Oncol 16(4):e165–e172

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ou M, Li S, Tang L (2018) PRDM14: a potential target for cancer therapy. Curr Cancer Drug Targets 18(10):945–956

Article  CAS  PubMed  Google Scholar 

Pasqualetti G, Ricciardi S, Mey V, Del Tacca M, Danesi R (2011) Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines. Lung Cancer (Amsterdam, Netherlands) 74(2):197–205

Article  PubMed  Google Scholar 

Raquel-Cunha A, Cardoso-Carneiro D, Reis RM, Martinho O (2019) Current status of Raf kinase inhibitor protein (RKIP) in lung cancer: behind RTK signaling. Cells 8(5):442

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ren G, Baritaki S, Marathe H, Feng J, Park S, Beach S, Bazeley PS, Beshir AB, Fenteany G, Mehra R, Daignault S, Al-Mulla F, Keller E, Bonavida B, de la Serna I, Yeung KC (2012) Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer. Can Res 72(12):3091–3104

Article  CAS  Google Scholar 

Seki Y (2018) PRDM14 Is a unique epigenetic regulator stabilizing transcriptional networks for pluripotency. Front Cell Dev Biol 6:12

Article  PubMed  PubMed Central  Google Scholar 

Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30

PubMed  Google Scholar 

Tian H, Yin L, Ding K, Xia YY, Wang XH, Wu JZ, He X (2018) Raf1 is a prognostic factor for progression in patients with non-small cell lung cancer after radiotherapy. Oncol Rep 39(4):1966–1974

CAS  PubMed  Google Scholar 

Tomasini P, Walia P, Labbe C, Jao K, Leighl NB (2016) Targeting the KRAS pathway in non-small cell lung cancer. Oncologist 21(12):1450–1460

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tsiambas E, Mastronikolis N, Fotiades PP, Kyrodimos E, Chrysovergis A, Papanikolaou V, Mastronikolis S, Peschos D, Roukas D, Ragos V (2020) c-Jun/c-Fos complex in laryngeal squamous cell carcinoma. J BUON 25(2):618–620

PubMed  Google Scholar 

Wang Q, Wu X, Wu T, Li GM, Shi Y (2014) Clinical significance of RKIP mRNA expression in non-small cell lung cancer. Tumour Biol 35(5):4377–4380

Article  CAS  PubMed  Google Scholar 

Wang A, Duan G, Zhao C, Gao Y, Liu X, Wang Z, Li W, Wang K, Wang W (2017) Reduced RKIP expression levels are associated with frequent non-small cell lung cancer metastasis and STAT3 phosphorylation and activation. Oncol Lett 13(5):3039–3045

Article  CAS  PubMed  PubMed Central